Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesReceivables - Net
Ratios

Regen BioPharma (RGBPP) Rent Expense (2016 - 2024)

Regen BioPharma (RGBPP) has disclosed Rent Expense for 11 consecutive years, with $17215.0 as the latest value for Q1 2024.

  • On a quarterly basis, Rent Expense rose 14.77% to $17215.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $62215.0, a 3.69% increase, with the full-year FY2022 number at $50000.0, up 100.0% from a year prior.
  • Rent Expense was $17215.0 for Q1 2024 at Regen BioPharma, up from $15000.0 in the prior quarter.
  • In the past five years, Rent Expense ranged from a high of $17215.0 in Q1 2024 to a low of $3548.0 in Q1 2020.
  • A 5-year average of $12796.6 and a median of $15000.0 in 2021 define the central range for Rent Expense.
  • Peak YoY movement for Rent Expense: crashed 76.35% in 2020, then skyrocketed 200.0% in 2022.
  • Regen BioPharma's Rent Expense stood at $3548.0 in 2020, then skyrocketed by 40.92% to $5000.0 in 2021, then surged by 200.0% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then rose by 14.77% to $17215.0 in 2024.
  • Per Business Quant, the three most recent readings for RGBPP's Rent Expense are $17215.0 (Q1 2024), $15000.0 (Q2 2023), and $15000.0 (Q1 2023).